This interview took place at the Deep Learning in Healthcare Summit in London, 2016.
Dr Sobia Hamid recently wrote a paper for The Wilberforce Society advising policy makers on the opportunities and risks of artificial intelligence in medicine and healthcare. Sobia has been working in the area of personalised medicine and machine learning undertaking scientific and commercial due diligence and marketing for venture capital, biotech and pharma companies. Sobia completed her PhD in Epigenetics at the University of Cambridge, undertaking her research into genomic imprinting at The Babraham Institute. In 2011 Sobia founded Data Insights Cambridge, a networking community for data scientists.